SPOTLIGHT: JAMA editor scolds Pfizer for subpoenas

The Journal of the American Medical Association lambasted Pfizer for threatening the "integrity" of its peer-review-based decision-making system by subpoenaing peer reviews for its Celebrex and Bextra defense. After posting that editorial on JAMA's website, editor Catherine DeAngelis told the WSJ Health Blog that a medical journal "may as well pack it up and go home" if it gave drugmakers the kind of information Pfizer wanted. Report